Placebo to match LY3372689 clinical trials

I9X-MC-MTAE: Assessment of Safety, Tolerability, and Efficacy of LY3372689 in Early Symptomatic Alzheimer’s Disease

This study is looking into a new medication for people in the early stages of Alzheimer's disease. Researchers want to see if the medication, called LY3372689, is safe, has side effects, and if it helps improve or slow down symptoms compared to a dummy treatment.